THE UNIV OF IOWA RESEARCH FOUNDATION has a total of 16 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2002. It filed its patents most often in United States, Australia and China. Its main competitors in its focus markets biotechnology, pharmaceuticals and medical technology are HELMHOLTZ ZENTRUM MUNCHEN DEUTSCHES FORSCHUNGSZENTRUM FUR GESUNDHEIT UND UMWELT GMBH, TRANSKARYOTIC THERAPIES INC and MOGAM BIOTECH RES INST.
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Medical technology | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Diagnosis and surgery | |
#6 | Object sterilising | |
#7 | Implantable devices | |
#8 | Measuring microorganism processes | |
#9 | Fermentation | |
#10 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Stapleton Jack T | 4 |
#2 | Kumar Vijay | 3 |
#3 | Grossbach Andrew | 3 |
#4 | Xiang Jinhau | 3 |
#5 | Mclinden James | 3 |
#6 | Viljoen Stephanus V | 3 |
#7 | Bhattarai Nirjal | 3 |
#8 | Davidson Bev | 3 |
#9 | Schwarz Chaid | 2 |
#10 | Raghavan Madhavan | 2 |
Publication | Filing date | Title |
---|---|---|
US2018296559A1 | Treatment of airway smooth muscle dysfunction | |
AU2016366783A1 | Methods of producing biosynthetic bacterial cellulose membranes | |
CN107002079A | It is used as immunomodulator and the viral RNA segment of vaccine component |